My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

65.49 +0.24 (+0.37%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

44 45 Next >

3 Medtech Companies with Higher Future Share Prices

April 24, 2023

The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond.

Via MarketBeat

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review ↗

April 21, 2023

The major indexes saw modest declines, holding in a range.

Via Investor's Business Daily

Elliott Wave Technical Analysis: DexCom Inc ↗

April 21, 2023

Looking for further upside into wave (C) as we have broken through the confirmation level (green line).

Via Talk Markets

$100 Invested In DexCom 5 Years Ago Would Be Worth This Much Today ↗

April 17, 2023

Via Benzinga

Where DexCom Stands With Analysts ↗

April 17, 2023

Via Benzinga

What To Know About Raymond James's Upgrade of DexCom ↗

April 17, 2023

Via Benzinga

The Medicare Decision That Propelled Dexcom Stock Closer To A Breakout ↗

April 17, 2023

Now, 1.5 million more Americans will have access to CGMs, Dexcom said.

Via Investor's Business Daily

Diversified Abbott Laboratories Could Reverse And Move Higher

April 19, 2023

Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline.

Via MarketBeat

Physician Checks And Latest Script Data Support DexCom Growth Opportunity: Bullish Analyst Upgrades Stock ↗

April 17, 2023

Via Benzinga

Visa To Rally 15%? Here Are 10 Other Analyst Forecasts For Monday ↗

April 17, 2023

Raymond James boosted the price target for DexCom, Inc. (NASDAQ: DXCM) from $127 to $138. Raymond James analyst Jayson Bedford upgraded the stock from Outperform to Strong Buy. DexCom shares rose 1.8%...

Via Benzinga

Healthcare Innovation Drives Medical Device Makers To New Highs

April 17, 2023

Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.

Via MarketBeat

P/E Ratio Insights for DexCom ↗

April 07, 2023

Via Benzinga

Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗

March 31, 2023

Via Benzinga

Analyst Ratings for DexCom ↗

March 29, 2023

Via Benzinga

Where Will DexCom Be in 1 Year? ↗

March 29, 2023

The company may only be scratching the surface of its target market.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗

April 17, 2023

Via Benzinga

Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin

April 17, 2023

From Dexcom, Inc.

Via Business Wire

Price Over Earnings Overview: DexCom ↗

March 23, 2023

Via Benzinga

2 Stocks That Turned $40,000 Into $1 Million in 10 Years ↗

April 13, 2023

Are these stocks still good buys today?

Via The Motley Fool

Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, April 11 ↗

April 11, 2023

We are looking for further upside in wave (C) as we are seeing what appears to be a triangle in wave (B).

Via Talk Markets

1 Stock-Split Stock That's a Surefire April Buy and 1 to Avoid ↗

April 10, 2023

One stock-split stock is executing flawlessly and seeing its operating margin climb, while another widely held company is flashing warning signs.

Via The Motley Fool

A Nasdaq Bull Market Is Coming: 2 Fantastic Stocks to Buy and Hold ↗

April 08, 2023

Investing is a long-term game, and both of these companies are thinking that way.

Via The Motley Fool

3 No-Brainer Medical Device Stocks to Buy Right Now ↗

April 06, 2023

These companies have consistently delivered revenue and EPS gains.

Via The Motley Fool

Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time

April 06, 2023

From DexCom, Inc.

Via Business Wire

2 Explosive Growth Stocks to Buy in April ↗

April 05, 2023

These businesses look to be on solid footing even in a difficult operating environment.

Via The Motley Fool

Dexcom Publishes Annual Sustainability Report

April 05, 2023

From DexCom, Inc.

Via Business Wire

2 All-Weather Stocks to Buy Without Hesitation Right Now ↗

March 31, 2023

Despite near-term economic clouds, long-term investors can still find compelling buying opportunities.

Via The Motley Fool

Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend ↗

March 25, 2023

These red-hot stocks keep climbing despite the bear market.

Via The Motley Fool

Have $1,000? 2 Stock-Split Companies to Add to Your Buy Basket Right Now. ↗

March 23, 2023

Don't overlook these names in the current market.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 ↗

March 29, 2023

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.